pegcetacoplan
sobi,Apellis Pharmaceuticals
['sobi']
apellis and sobi report new data reinforcing the robust efficacy and safety profile of empaveli for pnh at eha 2022 congress $apls 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice